Abstracts tagged "Depression and rheumatoid arthritis (RA)"

Abstract Number: 2311 • 2019 ACR/ARP Annual Meeting
Association of Sexual Dysfunction and Depression in Rheumatoid Arthritis Female Patients
Bruna Piola ¹, Pedro Santos ², Flávia Barros ², Hugo Lima ², Paulo Cerquinho ², Rafael Caminha ², Dennys Fagundes ², Leia Andrade ², Felipe Torres ², Mariana Luna ² and Laurindo Rocha Jr², ¹Instituto de Medicina Integral Professor Fernando Figueira -IMIP, Recife, Pernambuco, Brazil, ²Instituto de Medicina Integral Professor Fernando Figueira - IMIP, Recife, Pernambuco, Brazil
Background/Purpose: Rheumatoid arthritis (RA) is a chronic disease that affects joints and is associated with many aspects of the patients´ lives, including sexual function and…
Abstract Number: 1510 • 2018 ACR/ARHP Annual Meeting
Depression Is a Major Driver of Functional Capacity in Patients with Rheumatoid Arthritis Regardless of Disease Activity
Carolina Ayelen Isnardi¹, Dafne Capelusnik², Emilce E Schneeberger³, Marcela Bazzarelli⁴, Laura Barloco⁵, Eliana Soledad Blanco⁶, Alejandro Benitez⁷, Federico Lujan Benavidez⁶, Santiago Scarafia⁸, María Alicia Lázaro⁸, Rodolfo Perez-Alamino⁹, Francisco Colombres¹⁰, María Paula Kohan¹¹, Julia Sosa¹¹, Luciana Gonzalez Lucero¹², Ana Lucia Barbaglia¹², Hernán Maldonado Ficco¹³ and Gustavo Citera¹⁴, ¹Reumatology, Instituto de Rehabilitación Psicofísica, CABA, Argentina, ²Reumatology, Instituto de Rehabilitación Psicofísica, Argentina, CABA, Argentina, ³Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁴Reumatology, Hospital Interzonal General de Agudos Petrona V. de Cordero, Buenos Aires, Argentina, ⁵Terapia Ocupacional, Hospital Interzonal General de Agudos Petrona V. de Cordero, Buenos Aires, Argentina, ⁶Reumatology, Hospital General de Agudos Dr. Cosme Argerich, CABA, Argentina, ⁷Rheumatology, Hospital Cosme Argerich, Ciudad de Buenos Aires, Buenos Aires, Argentina, ⁸Reumatology, Instituto de Asistencia Reumatológica Integral, Buenos Aires, Argentina, ⁹Rheumatology Department, Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina, ¹⁰Reumatology, Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucuman, Argentina, ¹¹Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, Argentina, CABA, Argentina, ¹²Hospital Angel C. Padilla, Tucuman, Argentina, ¹³Rheumatology Section, Hospital San Antonio de Padua, Río Cuarto- Córdoba, Argentina, ¹⁴Rheumatology Section, Instituto de Rehabilitación Psicofísica, CABA, Argentina
Background/Purpose: Depression is one of the most frequent comorbidity in RA patients. It´s presence is associated with higher healthcare costs, mortality rate and reduced odds…
Abstract Number: 1545 • 2018 ACR/ARHP Annual Meeting
Exploring the Effects of Depressive Symptoms on the Efficacy of Sarilumab and Improvements in Health-Related Quality of Life
Vibeke Strand¹, Erin Mangan², Owen Hagino³, Jonathan Sadeh⁴, Susan Boklage² and Toshio Kimura², ¹Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA, ²Regeneron Pharmaceuticals, Inc., Tarrytown, NY, ³Sanofi Genzyme, Bridgewater, NJ, ⁴Sanofi, Bridgewater, NJ
Background/Purpose: The pro-inflammatory cytokine IL-6 has been found to play a critical role in mood disorders, with symptoms such as anxiety and depression having implications…
Abstract Number: 121 • 2017 ACR/ARHP Annual Meeting
Depression As a Risk Factor for the Development of Rheumatoid Arthritis: A Population-Based Cohort Study
Isabelle Vallerand¹, Ryan Lewinson², Mark Lowerison¹, Alexandra Frolkis³, Gilaad Kaplan³, Andrew Bulloch⁴, Scott Patten¹ and Cheryl Barnabe⁵, ¹Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ²Biomedical Engineering Program, Schulich School of Engineering, University of Calgary, Calgary, AB, Canada, ³Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ⁴Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ⁵Division of Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: The underlying risk factors for the development of Rheumatoid Arthritis (RA) remain poorly understood; however, prospective studies have demonstrated that individuals with elevated Tumor…
Abstract Number: 140 • 2017 ACR/ARHP Annual Meeting
Estimating Prevalence and Cost of Depression Among Japanese RA Patients: A Retrospective Claims Data Base Analysis
Rosarin Sruamsiri¹, Jörg Mahlich² and Yuko Kaneko³, ¹Health Economics, Janssen Pharmaceutical KK,, Tokyo, Japan, ²Health Economics, Janssen Pharmaceutical KK, Tokyo, Japan, ³Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
Background/Purpose: Significant evidence in the scholarly literature suggests that depression is a common comorbidity among patients with rheumatoid arthritis (RA) causing significant burden for the…
Abstract Number: 1340 • 2017 ACR/ARHP Annual Meeting
Is Depression in Patients with Rheumatoid Arthritis Associated with Disease Activity? Comparative Study between Germany and Brazil
Harriet Morf¹, Olga Seifert², Geraldo Castelar-Pinheiro³, Ana Beatriz Vargas-Santos⁴ and C Baerwald⁵, ¹Department of Internal Medicine, University Hospital, Erlangen, Germany, ²University of Leipzig, Leipzig, Germany, ³Universidade do Estado do Rio de Janeiro - UERJ, Rio de Janeiro, Brazil, ⁴Internal Medicine - Rheumatology, State University of Rio de Janeiro, Rio de Janeiro, Brazil, ⁵Department of Rheumatology, University of Leipzig, Germany, Leipzig, Germany
Background/Purpose: Rheumatoid Arthritis (RA) can be associated with psychologic disorders and especially depression. About 13–20% of patients have clinical significant depression (Matcham F et al,…
Abstract Number: 562 • 2016 ACR/ARHP Annual Meeting
Does Surgical Intervention to the Upper Extremity Make the Patients with Rheumatoid Arthritis Happy?
Asami Abe¹, Hajime Ishikawa² and Akira Murasawa³, ¹Rheumatplogy, Niigata Rheumatic Center, Shibata, Japan, ²Niigata Rheumatic Center, Shibata, Japan, ³Department of Rheumatology, Niigata Rheumatic Center, Shibata, Japan
Background/Purpose: Disease activity dramatically ameliorated with the use of bDMARD or a recently appeared tsDMARD and more than one-half of the patients with RA were…
Abstract Number: 1261 • 2016 ACR/ARHP Annual Meeting
Reliability and Validity of the Patient Health Questionnaire-9 for Assessment of Depression in Socioeconomically Disadvantaged Latinos with Rheumatoid Arthritis Living in the United States
Sarah Ormseth¹, Taylor Draper², Elizabeth Hernandez¹ and George A. Karpouzas³, ¹Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, ²Psychology, Loma Linda University, Loma Linda, CA, ³Harbor UCLA Medical Center, Torrance, CA
Background/Purpose: Depression is highly prevalent in rheumatoid arthritis (RA). The Patient Health Questionnaire-9 (PHQ-9) is a simple screening tool widely used in medical settings and…
Abstract Number: 1535 • 2016 ACR/ARHP Annual Meeting
Depression in Rheumatoid Arthritis
Christian Ferro¹, Carlos Ríos², Mario Moreno Alvarez³, Maria Jose Intriago⁴, Génessis Maldonado⁴, Claudia Aguirre⁴, Carlos Paredes⁴, Jenny Cardenas⁴, Nelson Cordova⁵, Rafael López⁵ and Jose Martinez⁵, ¹Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador, ²Centro de Reumatología y Rehabilitación CERER, Guayaquil, Ecuador, ³Rheumatology, Hospital Luis Vernaza, Rheumatology Service, Guayaquil, Ecuador, ⁴Universidad Espíritu Santo, Guayaquil, Ecuador, ⁵Hospital Luis Vernaza, Guayaquil, Ecuador
Background/Purpose: Depression is an important comorbidity in patients with rheumatoid arthritis (RA). Its incidence is variable (10-25%), being more frequent in women1. Wolfe et al.…
Abstract Number: 1539 • 2016 ACR/ARHP Annual Meeting
Physician-Reported and Patient-Reported Anxiety and Depression in Rheumatoid Arthritis
Nan Li¹, Emma Sullivan², Stuart Blackburn², Danuta Kielar¹ and Steve Peterson¹, ¹Janssen Research & Development, LLC, Spring House, PA, ²Adelphi Real World, Manchester, United Kingdom
Background/Purpose: As many as 40% of people with rheumatoid arthritis (RA) experience significant symptoms of mood disorders. In addition to the pain, fatigue, and disability…
Abstract Number: 2673 • 2015 ACR/ARHP Annual Meeting
Association Between Anxiety and Depression and Rheumatoid Disease Severity: Results from an Established Rheumatoid Arthritis Cohort
Faith Matcham¹, Sam Norton^2,3, Nicola Goodson⁴, Samantha Hider⁵, Matthew Hotopf⁶ and James Galloway⁷, ¹Psychological Medicine Clinical Academic Group, King's College London, London, United Kingdom, ²Department of Psychological Medicine, King´s College London, London, United Kingdom, ³Institute of Psychiatry, King's College London, London, United Kingdom, ⁴Rheumatology, University of Liverpool, Liverpool, United Kingdom, ⁵Research Institute for Primary Care and Health Sciences, Keele University, Keele, United Kingdom, ⁶Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom, ⁷Academic Department of Rheumatology, King´s College London, London, United Kingdom
Background/Purpose: Depression is highly prevalent in RA. In trials, depression has been found to be associated with higher disease activity and impaired treatment response. However…
Abstract Number: 1044 • 2013 ACR/ARHP Annual Meeting
Temporal Associations Of Prevalent Depression With The Different Domains Of Rheumatoid Arthritis Disease Activity
Alan Rathbun¹, Leslie R. Harrold² and George Reed³, ¹Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, MA, ²University of Massachusetts Medical School, Worcester, MA, ³Division of Behavioral and Preventive Medicine, University of Massachusetts Medical School, Worcester, MA
Background/Purpose: Depression (DEP) is a common psychiatric comorbidity of rheumatoid arthritis (RA), yet little is known of its temporal effect on disease activity and symptoms. …
Abstract Number: 375 • 2013 ACR/ARHP Annual Meeting
Systemic Inflammation Contributes To Depression In Patients With Rheumatoid Arthritis
Mary Margaretten¹, Laura Trupin², Patricia P. Katz², Gabriela Schmajuk², Jinoos Yazdany², Chris Tonner², Jennifer Barton² and Edward H. Yelin³, ¹Rheumatology, University of California, San Francisco, San Francisco, CA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³Arthritis Research Group, University of California, San Francisco, San Francisco, CA
Background/Purpose: Prior research suggests that systemic inflammation contributes to the pathogenesis of depression, but longitudinal studies in patients with rheumatoid arthritis (RA) are lacking. Comorbid…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].